Cintirorgon

N/A

Report date: 2024/11/19 20:00:10
NME

Base Information

Drug NameCintirorgon
Drug Alias NameLYC-55716
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma agonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLycera Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLycera Corp
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A